Global Pharmerging Market Size, Status and Forecast 2022

Publisher Name :
Date: 07-Dec-2017
No. of pages: 116
Inquire Before Buying

This report studies the global Pharmerging market, analyzes and researches the Pharmerging development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

- Pfizer

- Sanofi

- GlaxoSmithKline

- AstraZeneca

- Novartis

- Johnson & Johnson

- F. Hoffmann-La Roche

- Eli Lilly

- Boehringer Ingelheim

- Novo Nordisk

- AbbVie

- Sun Pharmaceutical

- Teva Pharmaceutical Industries

- Mitsubishi Tanabe Pharma

- Bristol-Myers Squibb

- Kyowa Hakko Kirin

- CSL Behring

- Shire

- Amgen

- Bayer

- Biogen

- Eisai

- Daiichi Sankyo

- Dainippon Sumitomo Pharma

Market segment by Regions/Countries, this report covers

- United States

- EU

- Japan

- China

- India

- Southeast Asia

Market segment by Type, the product can be split into

- Tier 1

- Tier 2

- Tier 3

Market segment by Application, Pharmerging can be split into

- Lung Cancer

- Breast Cancer

- Chronic Myeloid Leukemia

- Lymphomas

- Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Pharmerging Market Size, Status and Forecast 2022

Table of Contents
Global Pharmerging Market Size, Status and Forecast 2022
1 Industry Overview of Pharmerging
1.1 Pharmerging Market Overview
1.1.1 Pharmerging Product Scope
1.1.2 Market Status and Outlook
1.2 Global Pharmerging Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Pharmerging Market by Type
1.3.1 Tier 1
1.3.2 Tier 2
1.3.3 Tier 3
1.4 Pharmerging Market by End Users/Application
1.4.1 Lung Cancer
1.4.2 Breast Cancer
1.4.3 Chronic Myeloid Leukemia
1.4.4 Lymphomas
1.4.5 Other
2 Global Pharmerging Competition Analysis by Players
2.1 Pharmerging Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Pfizer
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Pharmerging Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Sanofi
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Pharmerging Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 GlaxoSmithKline
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Pharmerging Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 AstraZeneca
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Pharmerging Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Novartis
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Pharmerging Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Johnson & Johnson
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Pharmerging Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 F. Hoffmann-La Roche
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Pharmerging Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Eli Lilly
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Pharmerging Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Boehringer Ingelheim
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Pharmerging Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Novo Nordisk
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Pharmerging Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 AbbVie
3.12 Sun Pharmaceutical
3.13 Teva Pharmaceutical Industries
3.14 Mitsubishi Tanabe Pharma
3.15 Bristol-Myers Squibb
3.16 Kyowa Hakko Kirin
3.17 CSL Behring
3.18 Shire
3.19 Amgen
3.20 Bayer
3.21 Biogen
3.22 Eisai
3.23 Daiichi Sankyo
3.24 Dainippon Sumitomo Pharma
4 Global Pharmerging Market Size by Type and Application (2012-2017)
4.1 Global Pharmerging Market Size by Type (2012-2017)
4.2 Global Pharmerging Market Size by Application (2012-2017)
4.3 Potential Application of Pharmerging in Future
4.4 Top Consumer/End Users of Pharmerging
5 United States Pharmerging Development Status and Outlook
5.1 United States Pharmerging Market Size (2012-2017)
5.2 United States Pharmerging Market Size and Market Share by Players (2016 and 2017)
6 EU Pharmerging Development Status and Outlook
6.1 EU Pharmerging Market Size (2012-2017)
6.2 EU Pharmerging Market Size and Market Share by Players (2016 and 2017)
7 Japan Pharmerging Development Status and Outlook
7.1 Japan Pharmerging Market Size (2012-2017)
7.2 Japan Pharmerging Market Size and Market Share by Players (2016 and 2017)
8 China Pharmerging Development Status and Outlook
8.1 China Pharmerging Market Size (2012-2017)
8.2 China Pharmerging Market Size and Market Share by Players (2016 and 2017)
9 India Pharmerging Development Status and Outlook
9.1 India Pharmerging Market Size (2012-2017)
9.2 India Pharmerging Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Pharmerging Development Status and Outlook
10.1 Southeast Asia Pharmerging Market Size (2012-2017)
10.2 Southeast Asia Pharmerging Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Pharmerging Market Size (Value) by Regions (2017-2022)
11.1.1 United States Pharmerging Revenue and Growth Rate (2017-2022)
11.1.2 EU Pharmerging Revenue and Growth Rate (2017-2022)
11.1.3 Japan Pharmerging Revenue and Growth Rate (2017-2022)
11.1.4 China Pharmerging Revenue and Growth Rate (2017-2022)
11.1.5 India Pharmerging Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Pharmerging Revenue and Growth Rate (2017-2022)
11.2 Global Pharmerging Market Size (Value) by Type (2017-2022)
11.3 Global Pharmerging Market Size by Application (2017-2022)
12 Pharmerging Market Dynamics
12.1 Pharmerging Market Opportunities
12.2 Pharmerging Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Pharmerging Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Pharmerging Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Pharmerging Product Scope
Figure Global Pharmerging Market Size (Million USD) (2012-2017)
Table Global Pharmerging Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Pharmerging Market Share by Regions in 2016
Figure United States Pharmerging Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Pharmerging Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Pharmerging Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Pharmerging Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Pharmerging Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Pharmerging Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Pharmerging Market Share by Type in 2016
Figure Tier 1 Market Size (Million USD) and Growth Rate (2012-2017)
Figure Tier 2 Market Size (Million USD) and Growth Rate (2012-2017)
Figure Tier 3 Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Pharmerging Market Share by Application in 2016
Table Key Downstream Customer in Lung Cancer
Figure Pharmerging Market Size (Million USD) and Growth Rate in Lung Cancer (2012-2017)
Table Key Downstream Customer in Breast Cancer
Figure Pharmerging Market Size (Million USD) and Growth Rate in Breast Cancer (2012-2017)
Table Key Downstream Customer in Chronic Myeloid Leukemia
Figure Pharmerging Market Size (Million USD) and Growth Rate in Chronic Myeloid Leukemia (2012-2017)
Table Key Downstream Customer in Lymphomas
Figure Pharmerging Market Size (Million USD) and Growth Rate in Lymphomas (2012-2017)
Table Key Downstream Customer in Other
Figure Pharmerging Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Pharmerging Market Size (Million USD) by Players (2016 and 2017)
Figure Pharmerging Market Size Share by Players in 2016
Figure Pharmerging Market Size Share by Players in 2017
Table Pfizer Basic Information List
Table Pharmerging Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Pharmerging Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Pharmerging Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Pharmerging Business Revenue Market Share in 2016
Table GlaxoSmithKline Basic Information List
Table Pharmerging Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Pharmerging Business Revenue Market Share in 2016
Table AstraZeneca Basic Information List
Table Pharmerging Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Pharmerging Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Pharmerging Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Pharmerging Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Pharmerging Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Pharmerging Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Basic Information List
Table Pharmerging Business Revenue (Million USD) of F. Hoffmann-La Roche (2012-2017)
Figure F. Hoffmann-La Roche Pharmerging Business Revenue Market Share in 2016
Table Eli Lilly Basic Information List
Table Pharmerging Business Revenue (Million USD) of Eli Lilly (2012-2017)
Figure Eli Lilly Pharmerging Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Pharmerging Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Pharmerging Business Revenue Market Share in 2016
Table Novo Nordisk Basic Information List
Table Pharmerging Business Revenue (Million USD) of Novo Nordisk (2012-2017)
Figure Novo Nordisk Pharmerging Business Revenue Market Share in 2016
Table AbbVie Basic Information List
Table Pharmerging Business Revenue (Million USD) of AbbVie (2012-2017)
Figure AbbVie Pharmerging Business Revenue Market Share in 2016
Table Sun Pharmaceutical Basic Information List
Table Pharmerging Business Revenue (Million USD) of Sun Pharmaceutical (2012-2017)
Figure Sun Pharmaceutical Pharmerging Business Revenue Market Share in 2016
Table Teva Pharmaceutical Industries Basic Information List
Table Pharmerging Business Revenue (Million USD) of Teva Pharmaceutical Industries (2012-2017)
Figure Teva Pharmaceutical Industries Pharmerging Business Revenue Market Share in 2016
Table Mitsubishi Tanabe Pharma Basic Information List
Table Pharmerging Business Revenue (Million USD) of Mitsubishi Tanabe Pharma (2012-2017)
Figure Mitsubishi Tanabe Pharma Pharmerging Business Revenue Market Share in 2016
Table Bristol-Myers Squibb Basic Information List
Table Pharmerging Business Revenue (Million USD) of Bristol-Myers Squibb (2012-2017)
Figure Bristol-Myers Squibb Pharmerging Business Revenue Market Share in 2016
Table Kyowa Hakko Kirin Basic Information List
Table Pharmerging Business Revenue (Million USD) of Kyowa Hakko Kirin (2012-2017)
Figure Kyowa Hakko Kirin Pharmerging Business Revenue Market Share in 2016
Table CSL Behring Basic Information List
Table Pharmerging Business Revenue (Million USD) of CSL Behring (2012-2017)
Figure CSL Behring Pharmerging Business Revenue Market Share in 2016
Table Shire Basic Information List
Table Pharmerging Business Revenue (Million USD) of Shire (2012-2017)
Figure Shire Pharmerging Business Revenue Market Share in 2016
Table Amgen Basic Information List
Table Pharmerging Business Revenue (Million USD) of Amgen (2012-2017)
Figure Amgen Pharmerging Business Revenue Market Share in 2016
Table Bayer Basic Information List
Table Pharmerging Business Revenue (Million USD) of Bayer (2012-2017)
Figure Bayer Pharmerging Business Revenue Market Share in 2016
Table Biogen Basic Information List
Table Pharmerging Business Revenue (Million USD) of Biogen (2012-2017)
Figure Biogen Pharmerging Business Revenue Market Share in 2016
Table Eisai Basic Information List
Table Pharmerging Business Revenue (Million USD) of Eisai (2012-2017)
Figure Eisai Pharmerging Business Revenue Market Share in 2016
Table Daiichi Sankyo Basic Information List
Table Pharmerging Business Revenue (Million USD) of Daiichi Sankyo (2012-2017)
Figure Daiichi Sankyo Pharmerging Business Revenue Market Share in 2016
Table Dainippon Sumitomo Pharma Basic Information List
Table Pharmerging Business Revenue (Million USD) of Dainippon Sumitomo Pharma (2012-2017)
Figure Dainippon Sumitomo Pharma Pharmerging Business Revenue Market Share in 2016
Table Global Pharmerging Market Size (Million USD) by Type (2012-2017)
Figure Global Pharmerging Market Size Share by Type in 2012
Figure Global Pharmerging Market Size Share by Type in 2013
Figure Global Pharmerging Market Size Share by Type in 2014
Figure Global Pharmerging Market Size Share by Type in 2015
Figure Global Pharmerging Market Size Share by Type in 2016
Figure Global Pharmerging Market Size Share by Type in 2017
Table Global Pharmerging Market Size (Million USD) by Application (2012-2017)
Figure Global Pharmerging Market Size (Million USD) by Application in 2012
Figure Global Pharmerging Market Size (Million USD) by Application in 2013
Figure Global Pharmerging Market Size (Million USD) by Application in 2014
Figure Global Pharmerging Market Size (Million USD) by Application in 2015
Figure Global Pharmerging Market Size (Million USD) by Application in 2016
Figure Global Pharmerging Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Pharmerging
Figure United States Pharmerging Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Pharmerging Market Size (Million USD) by Players (2012-2017)
Figure United States Pharmerging Market Size Share by Players in 2016
Figure United States Pharmerging Market Size Share by Players in 2017
Figure EU Pharmerging Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Pharmerging Market Size (Million USD) by Players (2012-2017)
Figure EU Pharmerging Market Size Share by Players in 2016
Figure EU Pharmerging Market Size Share by Players in 2017
Figure Japan Pharmerging Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Pharmerging Market Size (Million USD) by Players (2012-2017)
Figure Japan Pharmerging Market Size Share by Players in 2016
Figure Japan Pharmerging Market Size Share by Players in 2017
Figure China Pharmerging Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Pharmerging Market Size (Million USD) by Players (2012-2017)
Figure China Pharmerging Market Size Share by Players in 2016
Figure China Pharmerging Market Size Share by Players in 2017
Figure India Pharmerging Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Pharmerging Market Size (Million USD) by Players (2012-2017)
Figure India Pharmerging Market Size Share by Players in 2016
Figure India Pharmerging Market Size Share by Players in 2017
Figure Southeast Asia Pharmerging Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Pharmerging Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Pharmerging Market Size Share by Players in 2016
Figure Southeast Asia Pharmerging Market Size Share by Players in 2017
Figure Global Pharmerging Market Size (Million USD) by Regions (2017-2022)
Table Global Pharmerging Market Size (Million USD) by Regions (2017-2022)
Figure Global Pharmerging Market Size Share by Regions in 2017
Figure Global Pharmerging Market Size Share by Regions in 2022
Figure United States Pharmerging Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Pharmerging Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Pharmerging Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Pharmerging Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Pharmerging Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Pharmerging Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Pharmerging Market Size (Million USD) by Type (2017-2022)
Figure Global Pharmerging Market Size Share by Type in 2017
Figure Global Pharmerging Market Size Share by Type in 2022
Table Global Pharmerging Market Size (Million USD) by Application (2017-2022)
Figure Global Pharmerging Market Size (Million USD) by Application in 2017
Figure Global Pharmerging Market Size (Million USD) by Application in 2022
  • Global Pizotifen Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pizotifen market status and forecast, categorizes the global Pizotifen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Pizotifen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturer......
  • Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 35
    Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) pipel......
  • Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 37
    Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2018 Summary Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Transglutaminase 2 (TG2) is a member of the transglutaminase family tha......
  • Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 40
    Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2018 Summary Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Respiratory syncytial virus G protein is a protein produced by respiratory syncytial virus. It attaches the virion to the host cell membrane by interacting with heparan sulfate. It interacts with host CX3CR1, the receptor for the CX3C chemokine fractalkine, to modulate the immune response and facilitate in......
  • Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 70
    Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2018 Summary Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) pipeline Target constitutes close to 15 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The latest report Survival Motor Neuron Protein - Pipeline Review, H2 2018, outlays comprehensive information on the S......
  • NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 65
    NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'NT 3 Growth Factor Receptor - Pipeline Review, H2 2018'; NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) pipeline Target constitutes close to 7 molecules. ......
  • MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 41
    MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response to environmental ......
  • BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 129
    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'BDNF NT 3 Growth Factors Receptor - Pipeline Review, H2 2018'; BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK......
  • Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 48
    Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 3 molecules are developed by compa......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs